APLS
XNASAPELLIS PHARMACEUTICALS INC
Avg. sentiment
0.30neutral
1 news · 90d
7d trend
——
0 news · vs previous 7d (—)
Breakdown
↑ 0• 1↓ 0
Sentiment velocity
+0.000→/day
Acceleration —
Sentiment scores computed by AI · Not investment advice.
No price data available for this ticker.
Track $APLS sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- GlobalNewswire5/14/2026, 12:35:00 PMBiogen Completes Acquisition of Apellis Pharmaceuticals
Biogen has completed its acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary. The deal closes Biogen's purchase of the complement-driven disease-focused biotech. No financial terms were disclosed in this announcement.
Sentiment 0.30Relevance 100%